Drug Profile
Research programme: G-protein coupled receptor modulators - Signum Biosciences
Alternative Names: SIG005Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Signum Biosciences
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Parkinson's-disease in USA
- 12 Oct 2010 Preclinical development is ongoing in USA
- 08 Oct 2008 Preclinical trials in Parkinson's disease in USA (unspecified route)